Therapeutic effect of bortezomib for primary plasma cell leukemia followed by auto/allo stem cell transplantation

Plasma cell leukemia (PCL) is a rare disease that represents approximately 4% of plasma cell malignant disorders. PCL consists of two variants: primary PCL presents in patients with no previous history of multiple myeloma, while secondary PCL consists of a leukemic transformation in a previously rec...

Descripción completa

Detalles Bibliográficos
Autores principales: Ozasa, Ryotaro, Hotta, Masaaki, Yoshimura, Hideaki, Nakanishi, Takahisa, Tamaki, Takeshi, Fujita, Shinya, Nakamichi, Naoto, Miyaji, Michihiko, Ishii, Kazuyoshi, Ito, Tomoki, Nomura, Shosaku
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2012
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3658252/
https://www.ncbi.nlm.nih.gov/pubmed/23754921
http://dx.doi.org/10.2147/IMCRJ.S33293

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3658252/
https://www.ncbi.nlm.nih.gov/pubmed/23754921
http://dx.doi.org/10.2147/IMCRJ.S33293

Ejemplares similares